Back to CBIO
BALYASNY ASSET MANAGEMENT L.P. → CBIO
BALYASNY ASSET MANAGEMENT L.P. CBIO Position History
Crescent Biopharma, Inc. • Healthcare
Quarters held
4
Latest value
$23.5M
Q3 2026
Peak value
$29.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.3M |
| Q1 2026 | $27.7M |
| Q2 2026 | $29.9M |
| Q3 2026 | $23.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $23.5M | 1.61M | — | — |
| Q2 2026 | $29.9M | 1.66M | — | — |
| Q1 2026 | $27.7M | 1.51M | — | — |
| Q4 2025 | $1.3M | 111.7K | — | — |
Other funds holding CBIO
$50.5M
$49.5M
$45.1M
$43.8M
$39.2M